SCHEMBL6312946

SCHEMBL6312946

O=C(O)Cc1ccc(/C=C/c2ccccc2)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1B1 P15121 1/20 0.64
LMNA P02545 2/20 0.61
ABCC4 O15439 1/20 0.61
GAA P10253 1/20 0.61
TSHR P16473 1/20 0.61
PTGS1 P23219 1/20 0.61
HTT P42858 1/20 0.61
FFAR1 O14842 1/20 0.55
CA2 P00918 1/20 0.54
CAMK2A Q9UQM7 1/20 0.54
PAM P19021 2/20 0.53
HDAC1 Q13547 2/20 0.50
CNR2 P34972 1/20 0.49
PPARA Q07869 1/20 0.49
CYP2C9 P11712 2/20 0.48
ALDH1A1 P00352 2/20 0.48
NSD2 O96028 1/20 0.48
POLB P06746 1/20 0.48
GRK2 P25098 1/20 0.48
CASP6 P55212 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6313137 1.00 AKR1B1 (0.64) AKR1B1LMNAABCC4GAATSHR
SCHEMBL7826031 0.90 AKR1B1 (0.57) AKR1B1LMNAABCC4GAATSHR
SCHEMBL8085700 0.88 AKR1B1 (0.64) AKR1B1LMNAABCC4GAATSHR
SCHEMBL16888910 0.88 CA2 (0.54) AKR1B1LMNAABCC4GAATSHR
SCHEMBL22046126 0.86 CA2 (0.76) AKR1B1LMNAABCC4GAATSHR
SCHEMBL27687200 0.86 AKR1B1 (0.56) AKR1B1LMNAABCC4GAATSHR
SCHEMBL11427146 0.85 CA2 (0.56) AKR1B1LMNAABCC4GAATSHR
SCHEMBL11427147 0.85 CA2 (0.56) AKR1B1LMNAABCC4GAATSHR
SCHEMBL6295521 0.85 PAM (0.56) AKR1B1LMNAABCC4GAATSHR
SCHEMBL6295520 0.85 PAM (0.56) AKR1B1LMNAABCC4GAATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12404221-B2 Methods of arene alkenylation UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) 2025-09-02 US disclosed
US-20230234900-A1 METHODS OF ARENE ALKENYLATION UNIVERSITY OF VIRGINIA PATENT FOUNDATION 2023-07-27 US disclosed
US-20200385374-A1 IMIDAZOLE-BASED ANTICANCER AGENTS AND DERIVATIVES THEREOF, AND METHODS OF MAKING AND USING SAME THE UNIVERSITY OF TOLEDO (US) 2020-12-10 US disclosed
US-20200385374-A1 IMIDAZOLE-BASED ANTICANCER AGENTS AND DERIVATIVES THEREOF, AND METHODS OF MAKING AND USING SAME THE UNIVERSITY OF TOLEDO (US) 2020-12-10 US disclosed
WO-2019036607-A1 IMIDAZOLE-BASED ANTICANCER AGENTS AND DERIVATIVES THEREOF, AND METHODS OF MAKING AND USING SAME THE UNIVERSITY OF TOLEDO (US) 2019-02-21 WO disclosed
US-6960667-B2 Fluorescent maleimides and uses thereof CIBA SPECIALTY CHEMICALS CORPORATION (US) 2005-11-01 US disclosed
US-20030189191-A1 Fluorescent maleimides and uses thereof KUNIMOTO KAZUHIKO (JP) 2003-10-09 US disclosed
US-6508957-B2 Ultraviolet fluorescent material for void detection and for preparation of scintillators, films, luminescent solar energy collectors, organic electroluminescent devices, printing inks, electrophotographic toners CIBA SPECIALTY CHEMICALS CORPORATION 2003-01-21 US disclosed
EP-1216285-A1 FLUORESCENT MALEIMIDES AND USES THEREOF Ciba SC Holding AG (CH) 2002-06-26 EP disclosed
US-20020065422-A1 Fluorescent maleimides and uses thereof KUNIMOTO KAZUHIKO (JP) 2002-05-30 US disclosed
US-6258954-B1 ELECTROLUMINESCENCE; DETECTION VOIDS CIBA SPECIALTY CHEMICALS CORP. 2001-07-10 US disclosed
WO-2001019939-A1 FLUORESCENT MALEIMIDES AND USES THEREOF CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2001-03-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020065422-A1 Fluorescent maleimides and uses thereof IK, PAH, MYO1F AKR1B1 1162/4885LMNA 1976/4885ABCC4 4587/4885
US-20030189191-A1 Fluorescent maleimides and uses thereof CBR1, CBR3, MT-CO2 AKR1B1 2386/4885LMNA 137/4885ABCC4 2576/4885
US-20230234900-A1 METHODS OF ARENE ALKENYLATION CYBB, CBR3, AHR AKR1B1 280/4885LMNA 1425/4885ABCC4 1685/4885
US-12404221-B2 Methods of arene alkenylation CYBB, CBR3, AHR AKR1B1 280/4885LMNA 1425/4885ABCC4 1685/4885
US-20200385374-A1 IMIDAZOLE-BASED ANTICANCER AGENTS AND DERIVATIVES THEREOF, AND METHODS OF MAKING AND USING SAME HDAC1, HDAC8, HDAC2 AKR1B1 2106/4885LMNA 2343/4885ABCC4 3210/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.